Author

M. Quraishi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-World Effectiveness and Safety of Advanced Combination Treatment in Patients with Refractory Inflammatory Bowel Disease.

INTRODUCTION Advanced combination treatment (ACT) pairs two advanced therapies with distinct mechanisms of action for inflammatory bowel disease (IBD) that has not responded to single agents. However, real-world evidence on individual regimens remains limited. METHODS We retrospectively identified all ACT courses at...

E. F. Ahmed, Camille Conde Oribiana, M. Alahmad et al. · Advances in Therapy · 0 citations

Review Open access Oct 2026

Subcutaneous infliximab in inflammatory bowel disease: from pharmacokinetic principles to clinical practice.

INTRODUCTION Subcutaneous infliximab (CT-P13 SC) was developed to address the pronounced peak-to-trough fluctuations of intravenous dosing and the immunogenicity driven by sub-therapeutic troughs. Through a stable steady-state pharmacokinetic profile it meets the international Delphi consensus definition of a biobetter...

M. N. Quraishi, S. Elouali · Expert Opinion on Biological... · 0 citations

Review Open access Aug 2026

Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.

This narrative review provides a contemporary appraisal of TL1A-directed therapeutics in inflammatory bowel disease based on electronic searches through May 2026, and discusses therapeutic positioning and timing, the opportunity in acute severe UC, and the unusual standing of IBD as the lead indication for this mechani...

M. N. Quraishi, V. Jairath, B. Al-Bawardy · Inflammatory Bowel Diseases · 0 citations